- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02191046
Effect of Squeezable Bottle Nasal Irrigation Device in Children With Sinusitis
October 31, 2014 updated by: araya satdhabudha, Thammasat University
A Randomized- Controlled Study Comparing the Effect of Squeezable Bottle Nasal Irrigation Device With Syringe in Children With Sinusitis
The purpose of this study is to the effect of squeezable bottle nasal irrigation device with syringe in children with sinusitis in symptom score and satisfaction to nasal irrigation
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
sinusitis is the one of common diseases in Thailand.
Nasal irrigation has been used as an adjunctive treatment.In previous study shown that buffer hypertonic nasal irrigation have more effective to decrease symptom in patient sinonasal disease when compare to normal saline.Until now, there are no clear data comparing the effectiveness on sinonasal symptom of the various devices use in children with sinusitis.
The purpose of this study was to compare the effect of squeezable bottle nasal irrigation device with syringe in children with sinusitis in symptom score and satisfaction to nasal irrigation.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pratumthanee
-
Klongluang, Pratumthanee, Thailand
- Araya Satdhabudha
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 15 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 3-15 years
- diagnose sinusitis by each of following criteria 2.1 persistent upper respiratory infection symptoms > or = 10 days 2.2. severe upper respiratory infection symptom with greenish discharge per nose or periorbital swelling 2.3 double sickening of upper respiratory infection symptoms
Exclusion Criteria:
- patient who has history of penicillin allergy
- patient who has complication of sinusitis
- patient with a history of nasal anatomical defects
- patient who has immune deficiency or primary ciliary dyskinesia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: syringe 20 ml
nasal irrigation with syringe by using buffer hypertonic saline about 100-240 ml until no nasal discharge
|
nasal irrigation twice daily for 2 weeks
|
|
Experimental: squeezable bottle
nasal irrigation with squeezable bottle by using buffer hypertonic saline about 100-240 ml until no nasal discharge
|
nasal irrigation twice daily for 2 weeks period
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the Effect of Squeezable Bottle and Syringe on Clinical Effectiveness in Sinusitis Children
Time Frame: compare 5S-score of both group at 2 week and at baseline visit .compare the mean 5S-score and satisfaction score between both group at 2 weeks after treatment
|
For 5S-score, we measured the the mean 5-s score of both group at 2 weeks compare to the mean 5-s score at baseline visit and compare 5S-score between group at 2 weeks.
The S5- score is a scale assessing severity of sinusitis.
It compose of the symptom scores for nasal obstruction, day and nighttime cough, headache and nasal discharge.
All symptom were graded from 0(no symptom) to 3 (severe ).The score were summed to give the mean 5S-score.It range from 0 (best possible outcome) to 15(worst possible outcome).
7-point Likert scale for satisfaction score is scale from 1 (indicating unsatisfactory) to 7 (indicating excellent).
For satisfaction, we reported the result in the term of 7 points Likert scale and compare these scale between group at 2 weeks after treatment
|
compare 5S-score of both group at 2 week and at baseline visit .compare the mean 5S-score and satisfaction score between both group at 2 weeks after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the Contamination in Nasal Irrigation Devices
Time Frame: at second week after treatment
|
compare the result of bacterial culture in both group of nasal irrigation devices.
We reported in the following item; no growth, gram positive or gram negative or mixed organism
|
at second week after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Araya Satdhabudha, MD, Thammasat University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
July 13, 2014
First Submitted That Met QC Criteria
July 14, 2014
First Posted (Estimate)
July 15, 2014
Study Record Updates
Last Update Posted (Estimate)
November 4, 2014
Last Update Submitted That Met QC Criteria
October 31, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ทป 45/2555
- 45/2555 (Other Grant/Funding Number: Thammasat research grant)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sinusitis
-
Loma Linda UniversityWithdrawnChronic Sinus Disease | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Maxillary Bilateral | Chronic Sinusitis - Frontoethmoidal
-
LifeBridge HealthUnknownChronic Sinusitis | Nasal Polyps | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Frontoethmoidal | Chronic Sinusitis - Ethmoidal, Posterior | Chronic Sinusitis - Ethmoidal Anterior | Nasal Polyp - PosteriorUnited States
-
Assiut UniversityNot yet recruitingDeviated Nasal Septum Effect on Maxillary Sinus Volumes and Development of Maxillary Sinusitis by CTDeviated Nasal Septum and Maxillary Sinusitis
-
Collin County Ear Nose & ThroatIntersect ENTCompletedChronic Sinusitis, EthmoidalUnited States
-
Tampere University HospitalRecruitingMaxillary Sinusitis | Eustachian Tube Dysfunction | Sinusitis, Chronic | Sinusitis RecurrentFinland
-
STS MedicalNot yet recruitingChronic Sinusitis, Ethmoidal
-
Ayu, Inc.CompletedSinusitis | Rhinosinusitis | Chronic Rhino-sinusitisMalaysia
-
Deraya UniversityCompleted
-
St. Louis UniversityTerminatedStent | Sinusitis, FrontalUnited States
-
Shanghai Yidian Pharmaceutical Technology Development...RecruitingChronic Sinusitis Without Nasal PolypsChina
Clinical Trials on syringe 20 ml
-
McMaster Children's HospitalCompleted
-
Suez Canal UniversityCompletedTemporomandibular Joint Disc DisplacementEgypt
-
Helwan UniversityNot yet recruitingSTEMI - ST Elevation Myocardial Infarction | Thrombosis CardiacEgypt
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisSpain, Germany, United States, Iceland, Canada, Poland
-
Kashiv BioSciences, LLCCliantha ResearchCompletedHealthy VolunteerUnited States
-
University Hospital, MontpellierRecruiting
-
Shaheed Zulfiqar Ali Bhutto Medical UniversityCompletedCytokine Release Syndrome | Covid-19 PneumoniaPakistan
-
Cairo UniversityNot yet recruiting
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGActive, not recruiting
-
Ankara City Hospital Bilkentİstem Medikal Tıbbi Cihaz ve Sanayi Ticaret Anonim ŞirketiNot yet recruiting